You have no items in your shopping cart.
All Products
Recombinant Rat CD38 (C-6His) [orb2994079]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.8 KDa. Observed: 35-50 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Cynomolgus CD38 (C-6His) [orb2994080]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.9 KDa. Observed: 38-50 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CD38 (C-mFc) [orb2994081]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.5 KDa. Observed: 70-90 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CD38 (C-Fc) [orb2994082]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57 KDa. Observed: 70-90 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CD157 (C-Fc) [orb2994083]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.1 KDa. Observed: 75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human APRIL (N-Flag-His) [orb2994084]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50 KDa. Observed: 60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human IL-22 (C-6His) [orb2994085]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 25-35 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human IL-22 [orb2994086]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.9 KDa. Observed: 25-35 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PSGL-1 (C-Fc) [orb2994087]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.9 KDa. Observed: 100-130 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Cynomolgus TIM-3 (N-8His) [orb2994088]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.8 KDa. Observed: 26-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg